(Q38848208)

7 September 2017

Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu). (English)

1 reference

7 September 2017

0 references

0 references

Sudan ebolavirus

1 reference

Ariel Sobarzo

1

0 references

Stephan Becker

4

object named as

Stephan Becker

1 reference

7 September 2017

Allison Groseth

2

1 reference

7 September 2017

Olga Dolnik

3

1 reference

7 September 2017

Julius Julian Lutwama

5

1 reference

7 September 2017

Eddie Perelman

6

1 reference

7 September 2017

Victoria Yavelsky

7

1 reference

7 September 2017

Majidat Muhammad

8

1 reference

7 September 2017

Ana I Kuehne

9

1 reference

7 September 2017

Robert S Marks

10

1 reference

7 September 2017

John M Dye

11

1 reference

7 September 2017

Leslie Lobel

12

1 reference

7 September 2017

language of work or name

English

0 references

publication date

12 April 2013

1 reference

Journal of Infectious Diseases

7 September 2017

1 reference

7 September 2017

208

1 reference

7 September 2017

2

1 reference

7 September 2017

299-309

1 reference

Ebolavirus and Marburgvirus: insight the Filoviridae family

7 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

21 January 2018

Ebola haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Emerging and re-emerging infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Evaluation of perceived threat differences posed by filovirus variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Functional CD8+ T cell responses in lethal Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Antibody-dependent enhancement of Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Epitopes involved in antibody-mediated protection from Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Immunoglobulin G in Ebola outbreak survivors, Gabon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Human asymptomatic Ebola infection and strong inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Seasonal variation in antibodies against Ebola virus in Kenyan fever patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

A shared structural solution for neutralizing ebolaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Validation of IgG-sandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Optical fiber immunosensor for the detection of IgG antibody to Rift Valley fever virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Functional mapping of the nucleoprotein of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Early immune responses accompanying human asymptomatic Ebola infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Structure-function analysis of the soluble glycoprotein, sGP, of Ebola virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Complex of a Protective Antibody with Its Ebola Virus GP Peptide Epitope: Unusual Features of a Vλx Light Chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT162

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIT162

1 reference

7 September 2017

1 reference